DGAP-News: MagForce AG appoints Barbara von Frankenberg as Communications & Investor Relations Vice President

DGAP-News: MagForce AG / Key word(s): Change of Personnel
MagForce AG appoints Barbara von Frankenberg as Communications & Investor
Relations Vice President

16.03.2016 / 08:30
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

MagForce AG appoints Barbara von Frankenberg as 
Vice President Communications & Investor Relations

Berlin, Germany, and Nevada, USA, March 16, 2016 - MagForce AG (Frankfurt,
Entry Standard, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device
company in the field of nanomedicine focused on oncology, announced today
that Mrs. Barbara von Frankenberg has joined MagForce as Vice President
Communications & Investor Relations. Barbara von Frankenberg will manage
Magforce's relations with investors and analysts in Europe and in the U.S.

Prior to joining MagForce, Barbara von Frankenberg spent 16 years as
Investor Relations Manager, holding senior roles with publicly listed
high-tech companies.

"Barbara von Frankenberg is a highly dynamic executive with more than 15
years of experience in finance and communication, making her an excellent
addition to our team. She will be one of the key liaisons between MagForce
and the investment community and she will also manage the Company's
Corporate Communications function", said Ben Lipps, CEO of MagForce.

About MagForce AG and MagForce USA, Inc.

MagForce AG, listed in the entry standard of the Frankfurt Stock Exchange
(MF6, ISIN: DE000A0HGQF5), together with its subsidiary MagForce USA, Inc.
is a leading medical device company in the field of nanomedicine focused on
oncology. The Group's proprietary NanoTherm therapy enables the targeted
treatment of solid tumors through the intratumoral generation of heat via
activation of superparamagnetic nanoparticles. Mithril Capital Management,
a growth-stage technology fund founded by Ajay Royan and Peter Thiel, along
with MagForce AG, are investors and strategic partners in MagForce USA,
Inc.

NanoTherm(TM), NanoPlan(R), and NanoActivator(R) are components of the
therapy and have received EU-wide regulatory approval as medical devices
for the treatment of brain tumors. MagForce, NanoTherm, NanoPlan, and
NanoActivator are trademarks of MagForce AG in selected countries.

For more information, please visit: www.magforce.com.  

Get to know our Technology: video (You Tube) 

Stay informed and subscribe to our mailing list. 

Disclaimer 

This release may contain forward-looking statements and information which
may be identified by formulations using terms such as "expects", "aims",
"anticipates", "intends", "plans", "believes", "seeks", "estimates" or
"will". Such forward-looking statements are based on our current
expectations and certain assumptions, which may be subject to a variety of
risks and uncertainties. The results actually achieved by MagForce AG may
substantially differ from these forward-looking statements. MagForce AG
assumes no obligation to update these forward-looking statements or to
correct them in case of developments, which differ from those, anticipated.



Contact:
   
Barbara von Frankenberg
Vice President
Communications & Investor Relations

T +49-30-308380-77
E-Mail: bfrankenberg@magforce.com     


---------------------------------------------------------------------------

16.03.2016 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------


   Language:    English                                               
   Company:     MagForce AG                                           
                Max-Planck-Straße 3                                   
                12489 Berlin                                          
                Germany                                               
   Phone:       +49 (0)30 308 380 0                                   
   Fax:         +49 (0)30 308 380 99                                  
   E-mail:      info@magforce.com                                     
   Internet:    www.magforce.com                                      
   ISIN:        DE000A0HGQF5                                          
   WKN:         A0HGQF                                                
   Listed:      Regulated Unofficial Market in Berlin, Dusseldorf,    
                Stuttgart; Open Market (Entry Standard) in Frankfurt  
 
 
   End of News    DGAP News Service  
---------------------------------------------------------------------------

445291 16.03.2016